Your browser doesn't support javascript.
loading
Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
Redrobe, John P; Nielsen, Alexander N.
Affiliation
  • Redrobe JP; Department of Affective Disorders, NeuroSearch A/S, Pederstrupvej 93, 2750 Ballerup, Denmark. redpau@hotmail.com
Behav Brain Res ; 198(2): 481-5, 2009 Mar 17.
Article in En | MEDLINE | ID: mdl-19162078
In an effort to investigate the potential antimanic-like activity of K(v)7 channel openers, we decided to test: (1) the subtype non-selective K(v)7 opener retigabine, (2) the K(v)7.4-K(v)7.5 (and K(v)7.5/3 heteromers) preferring channel opener BMS-204352 (Maxipost), and (3) the novel K(v)7.2/3 preferring channel opener ICA-27243, in the amphetamine (AMPH)+chlordiazepoxide (CDP)-induced hyperactivity paradigm in mice, a test often used to assess potential antimanic-like activity of novel compounds. Lithium and lamotrigine were included as positive controls. Pretreatment with lithium attenuated AMPH/CDP-induced hyperactivity, without affecting the activity of AMPH- or CDP-alone, and thus confirmed some predictive validity for the test paradigm. Pretreatment with lamotrigine significantly attenuated AMPH/CDP-induced effects, but also reduced motility when tested in the presence of CDP-alone. Pretreatment with retigabine or ICA-27243 attenuated AMPH/CDP-induced hyperactivity without affecting basal locomotor activity. In contrast, pretreatment with BMS-204352 failed to decrease AMPH/CDP-induced hyperactivity at lower doses (3 and 10 mg/kg). At higher doses BMS-204352 attenuated hyperactivity induced by the AMPH/CDP mix, but only at doses decreasing basal locomotor activity (30 and 60 mg/kg). None of the K(v)7 openers tested significantly affected AMPH-induced hyperactivity. In contrast, retigabine and ICA-27243 were shown to induce significant reductions in motility when administered in combination with CDP-alone. In conclusion, the results with lithium confirm some predictive validity for the test paradigm. However, our data highlight an important confounder for interpreting a role for K(v)7 channels in the alleviation of manic-like symptoms when employing the AMPH/CDP hyperactivity model in mice. It is imperative that relevant control studies (AMPH- and CDP-alone) be incorporated and reported routinely to enable thorough interpretation of data generated by means of this behavioural test.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bipolar Disorder / Antimanic Agents / KCNQ Potassium Channels / Central Nervous System Stimulants / Hyperkinesis / Anticonvulsants Type of study: Prognostic_studies Limits: Animals Language: En Journal: Behav Brain Res Year: 2009 Document type: Article Affiliation country: Denmark Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bipolar Disorder / Antimanic Agents / KCNQ Potassium Channels / Central Nervous System Stimulants / Hyperkinesis / Anticonvulsants Type of study: Prognostic_studies Limits: Animals Language: En Journal: Behav Brain Res Year: 2009 Document type: Article Affiliation country: Denmark Country of publication: Netherlands